Skip to the main content
The Crier

Investigational Medicinial Product (IMP) & Placebo Manufacture - IM Woman Trial

Your saved contracts

What the buyer wrote

Manufacturing and packing of IMP for the IM Woman Trial due to commence in March 2023. Three arms include experimental treatment (IM TXA), reference treatment/active control (IV TXA), and placebo control (0.9% sodium chloride solution). Treatment Kit Boxes required for 4 campaigns with approximately 10,000 patient packs per campaign. Recruitment period is 24 months - campaign approximately once every 6 months.

Bid for this and lost? There is a short window in which the decision can be questioned.

Details

What the buyer calls it
Investigational Medicinial Product (IMP) & Placebo Manufacture - IM Woman Trial
How they are buying
Advertised, open to anyoneAny supplier could bid without being invited first.
Type
goods
Where
in London

Who the buyer named

Sally Hopkin was the named contact on this notice.

sally.hopkin@lshtm.ac.uk